Insider trades
Bakker Juliet Tammenoms, Director of RxSight RXST, has filed 7 purchases and 15 sales on the open market. Over the past 12 months that comes to a net sale of $663.9K. The latest trade was on 06/17.
Bakker Juliet Tammenoms
Director
- Company
- RxSight RXST
- First filing
- 23/02/08
- Trades
- 51 trades
- Buys / sales
- 7 / 15
- 12-month net buying
- −$663.9K
- Last trade
- 06/17
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market sale | 02/04 | 02/06 | 49,000 sh | $3.88 | $190,120 | −100.0% | |
RPID | Open-market sale | 01/23–02/03 | 02/03 | 108,739 sh4 trades | $4.36avg. | $473,735.34 | −68.9% |
CeribellCBLL | Open-market buy | 24/10/15 | 24/10/16 | 237,234 sh | $17.00 | $4,032,978 | +10.6% |
RxSightRXST | Open-market buy | 24/05/17 | 24/05/21 | 5,000 sh | $61.09 | $305,450 | +16.8% |
RXST | Open-market buy | 24/02/12–24/02/14 | 24/02/15 | 8,000 sh2 trades | $50.84avg. | $406,680 | +36.6% |
RXST | Open-market sale | 23/11/28–23/11/29 | 23/11/30 | 494,313 sh2 trades | $29.73avg. | $14,693,937.81 | −100.0% |
RXST | Open-market sale | 23/11/14–23/11/15 | 23/11/16 | 500,000 sh2 trades | $27.19avg. | $13,593,000 | −50.3% |
| Open-market buy | 23/11/07 | 23/11/09 | 454,545 sh | $11.00 | $4,999,995 | +21.5% | |
RXST | Open-market sale | 23/09/07–23/09/11 | 23/09/11 | 32,950 sh3 trades | $30.14avg. | $993,034.45 | −62.0% |
RxSightRXST | Open-market sale | 23/08/25 | 23/08/28 | 16,208 sh | $29.25 | $474,084 | −23.4% |
RXST | Open-market sale | 23/08/17–23/08/18 | 23/08/18 | 33,135 sh2 trades | $29.62avg. | $981,533.61 | −32.6% |
RxSightRXST | Open-market buy | 23/02/10 | 23/02/13 | 480,000 sh | $12.50 | $6,000,000 | +96.0% |
| Open-market buy | 23/02/06 | 23/02/08 | 1,714,285 sh | $7.00 | $11,999,995 | No record |
